Your fact-checks will appear here
The importance of clinical trials in determining the efficacy and safety of treatments for dementia.
Honey shows biological properties—antioxidant, anti-inflammatory, and polyphenol-driven activities—that lab studies and animal models suggest could be neuroprotective and might modestly affect pathway...
No randomized controlled trials (RCTs) have tested combined spice‑and‑honey interventions specifically for Alzheimer’s disease (AD) or vascular dementia; the clinical literature contains RCTs of indiv...
Pregabalin and cholinesterase inhibitors produce distinct adverse-effect patterns in older adults: pregabalin primarily causes central nervous system effects (dizziness, somnolence) and has been assoc...